Cardiac magnetic resonance assessment of athletic myocardial fibrosis; Benign bystander or malignant marker?
Copyright © 2023 The Author. Published by Elsevier B.V. All rights reserved..
The benefits of exercise are irrefutable with a well-established dose-dependent relationship between exercise intensity and reduction in cardiovascular disease. Differentiating the physiological adaptation to exercise, termed the "athlete's heart" from cardiomyopathies, has been advanced by the advent of more sophisticated imaging modalities such as cardiac magnetic resonance imaging (CMR). Myocardial fibrosis on CMR is a mutual finding amongst seemingly healthy endurance athletes and individuals with cardiomyopathy. As a substrate for arrhythmias, fibrosis is traditionally associated with increased cardiovascular risk. In this article, we discuss the aetiologies, distribution and potential implications of myocardial fibrosis in athletes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 2023 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:394 |
---|---|
Enthalten in: |
International journal of cardiology - 394(2023) vom: 01. Jan., Seite 131382 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Javed, Wasim [VerfasserIn] |
---|
Links: |
---|
Themen: |
Athlete's heart |
---|
Anmerkungen: |
Date Completed 04.12.2023 Date Revised 04.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijcard.2023.131382 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362378347 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM362378347 | ||
003 | DE-627 | ||
005 | 20231226091120.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijcard.2023.131382 |2 doi | |
028 | 5 | 2 | |a pubmed24n1207.xml |
035 | |a (DE-627)NLM362378347 | ||
035 | |a (NLM)37741350 | ||
035 | |a (PII)S0167-5273(23)01341-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Javed, Wasim |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cardiac magnetic resonance assessment of athletic myocardial fibrosis; Benign bystander or malignant marker? |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.12.2023 | ||
500 | |a Date Revised 04.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Author. Published by Elsevier B.V. All rights reserved. | ||
520 | |a The benefits of exercise are irrefutable with a well-established dose-dependent relationship between exercise intensity and reduction in cardiovascular disease. Differentiating the physiological adaptation to exercise, termed the "athlete's heart" from cardiomyopathies, has been advanced by the advent of more sophisticated imaging modalities such as cardiac magnetic resonance imaging (CMR). Myocardial fibrosis on CMR is a mutual finding amongst seemingly healthy endurance athletes and individuals with cardiomyopathy. As a substrate for arrhythmias, fibrosis is traditionally associated with increased cardiovascular risk. In this article, we discuss the aetiologies, distribution and potential implications of myocardial fibrosis in athletes | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Cardiac magnetic resonance | |
650 | 4 | |a Late gadolinium enhancement | |
650 | 4 | |a Myocardial fibrosis | |
650 | 4 | |a Sports cardiology | |
650 | 4 | |a athlete's heart | |
700 | 1 | |a Malhotra, Aneil |e verfasserin |4 aut | |
700 | 1 | |a Swoboda, Peter |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of cardiology |d 1984 |g 394(2023) vom: 01. Jan., Seite 131382 |w (DE-627)NLM012621196 |x 1874-1754 |7 nnns |
773 | 1 | 8 | |g volume:394 |g year:2023 |g day:01 |g month:01 |g pages:131382 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijcard.2023.131382 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 394 |j 2023 |b 01 |c 01 |h 131382 |